ClinicalTrialsFinder
RecruitingNCT07279571

GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education

Sponsor

University of Southern California

Enrollment

48 participants

Start Date

Jun 12, 2026

Study Type

OBSERVATIONAL

Conditions

Endometrial Carcinoma

Summary

This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.

Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria9

  • AI-chatbot Evaluation (Aim 1):
  • Patient of the LA General gynecologic oncology clinic
  • Age 18 years or older
  • Previously obtained the HPV vaccination (initial chatbot evaluation)
  • Eligible for HPV vaccination (pilot intervention; age <46)
  • Willing and able to provide informed consent
  • Patient of the LA General gynecologic oncology clinic
  • Age 18 years or older
  • Obtained the HPV vaccine

Exclusion Criteria4

  • Patients who do not speak English or Spanish
  • Patients who do not provide informed consent
  • HPV vaccination rate (Aim 2):
  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Locations(2)

Los Angeles General Medical Center

Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07279571

Related Trials

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

NCT063659053 locations

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

NCT05256225408 locations

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT0591926433 locations

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

NCT072850441 location

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT0485111921 locations